Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference118 articles.
1. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy;Adelstein;J. Clin. Oncol.,2000
2. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity;Adelstein;Am. J. Clin. Oncol.,2007
3. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.[Erratum appears in Cancer 2000 Nov 15; 89 (10):2144];Adham;Cancer,2000
4. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer;Ajani;Oncology (Williston Park),2003
5. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction;Ajani;Cancer,2010
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synergistic effects of low‑dose chemotherapy and T cells in renal cell carcinoma;Oncology Reports;2020-07-07
2. Setup strategies and uncertainties in esophageal radiotherapy based on detailed intra- and interfractional tumor motion mapping;Radiotherapy and Oncology;2019-07
3. Novel-miR-4885 Promotes Migration and Invasion of Esophageal Cancer Cells Through TargetingCTNNA2;DNA and Cell Biology;2019-02
4. Validation of a robust strategy for proton spot scanning for oesophageal cancer in the presence of anatomical changes;Radiotherapy and Oncology;2019-02
5. Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling;PLOS ONE;2018-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3